Ocular toxicity of fluoroquinolones.
Thompson AM.
Clin Exp Ophthalmol. 2007 Aug;35(6):566-77. doi: 10.1111/j.1442-9071.2007.01552.x.
T Helper 2 IL-4/IL-13 Dual Blockade with Dupilumab Is Linked to Some Emergent T Helper 17‒Type Diseases, Including Seronegative Arthritis and Enthesitis/Enthesopathy, but Not to Humoral Autoimmune Diseases.
Bridgewood C, Wittmann M, Macleod T, Watad A, Newton D, Bhan K, Amital H, Damiani G, Giryes S, Bragazzi NL, McGonagle D.
J Invest Dermatol. 2022 Oct;142(10):2660-2667. doi: 10.1016/j.jid.2022.03.013. Epub 2022 Apr 6.
Brown Syndrome.
Fu L, Gurnani B, Malik J.
2024 Mar 3. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2025 Jan–.
Brown's syndrome.
Wilson ME, Eustis HS Jr, Parks MM.
Surv Ophthalmol. 1989 Nov-Dec;34(3):153-72. doi: 10.1016/0039-6257(89)90100-8.
Chemical burns.
Cartotto RC, Peters WJ, Neligan PC, Douglas LG, Beeston J.
Can J Surg. 1996 Jun;39(3):205-11.
Mitochondrial bioenergetics in ocular fibroblasts of two myasthenia gravis cases.
Europa TA, Nel M, Lebeko MR, Heckmann JM.
IBRO Neurosci Rep. 2022 Apr 21;12:297-302. doi: 10.1016/j.ibneur.2022.04.007. eCollection 2022 Jun.
Guillain-Barré syndrome.
Gurwood AS, Drake J.
Optometry. 2006 Nov;77(11):540-6. doi: 10.1016/j.optm.2006.06.014.
Brown syndrome--operate or observe?
Archer SM.
J AAPOS. 2009 Apr;13(2):115. doi: 10.1016/j.jaapos.2009.01.005.
Current concepts of mechanical and neural factors in ocular motility.
Demer JL.
Curr Opin Neurol. 2006 Feb;19(1):4-13. doi: 10.1097/01.wco.0000198100.87670.37.
[Transnasal canthopexy].
Laure B, Petraud A, Sury F, Goga D, Krastinova D.
Rev Stomatol Chir Maxillofac. 2010 Feb;111(1):36-42. doi: 10.1016/j.stomax.2009.04.003.
